Avience Biomedicals IPO

Lot size and investment

Reservation

QIB

6,83,400 shares (49.83% of the Offer)

NII

2,07,000 shares (15.09% of the Offer)

Retail

4,81,200 shares (35.08% of the Offer)

Current GMP

₹145

▲+69.70%

Estimated listing price

₹353

Issue price ₹208

Highest

₹145

25 Jun

Lowest

₹63

16 Jun

GMP by day (₹ per share)

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

P/E Ratio

16.56

EPS (₹)

12.56

RoCE

24.84%

RoNW

49.89%

PAT Margin

15.86%

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

Avience Biomedicals Limited was incorporated in 2019 as Avience Biomedicals Private Limited and was later converted into a public limited company. The company is promoted by Dharam Deo Choudhary, Ram Nagina Choudhary, Janardan Pal and Deepa Choudhary. Headquartered in New Delhi, the company has established itself in the healthcare diagnostics segment by focusing on quality-driven biomedical and diagnostic products. The company is engaged in the manufacturing and distribution of molecular diagnostic kits, reagents and related healthcare products used by hospitals, laboratories and diagnostic centres. Its business model is based on developing and supplying testing solutions that support disease detection and clinical diagnostics. With increasing demand for advanced healthcare testing infrastructure, the company aims to expand its product portfolio and market reach across India.

Objects of the issue

1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh₹14.05 Cr
2. Funding the working capital requirements of the Company₹8.25 Cr
3. General Corporate Purposes₹3.97 Cr
4. Public Issue Expenses₹3.97 Cr

Promoters and shareholding

Deepa Choudhary, Dharam Deo Choudhary, Janardan Pal and Ram Nagina Choudhary

Promoter holding, pre-issue

87.89%

Promoter holding, post-issue

64.59%